Literature DB >> 4846413

Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules.

G J Gleich, D A Loegering, F Kueppers, S P Bajaj, K G Mann.   

Abstract

Guinea pig eosinophil granules are characterized by the presence of a basic protein of low molecular weight which accounts for greater than 50% of granule protein. This protein, termed the major basic protein (MBP), readily aggregates and becomes insoluble, and the formation of aggregates is dependent on the establishment of disulfide bonds. Analysis of concentrated preparations of MBP often revealed a series of bands which were multiples of a monomeric unit with a mol wt of approximately 11,000. Analysis of reduced and alkylated MBP on a 10% agarose column equilibrated with 6 M guanidinium chloride revealed a single polypeptide chain with a mol wt of 10,800. Amino acid analysis of the protein revealed the presence of 13% arginine, consistent with the basic character of the molecule. Four residues of tryptophan, were present, indicating that MBP is not a histone. The MBP did not increase vascular permeability when injected into the skin of guinea pigs, nor did it antagonize the effect of histamine and bradykinin in the skin. MBP also did not contract the isolated guinea pig ileum and when mixed with histamine or bradykinin did not inhibit their activity on the gut. MBP had only weak, if any, antihistaminic activity. MBP possessed weak bactericidal activity when compared to histone and then only with one strain of E. coli. MBP precipitated DNA, neutralized heparin, and activated papain. On a molar basis MBP was more active than cysteine in activating papain. These results do not point to any unique biological activity associated with MBP other than those expected of a protein as basic as it is and one which possesses reactive sulfhydryl groups. Possible functions of eosinophils based on the properties of the MBP are discussed.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4846413      PMCID: PMC2139602          DOI: 10.1084/jem.140.2.313

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  A phagocytosis-promoting substance present in eosinophils.

Authors:  N BOSWORTH; G T ARCHER
Journal:  Aust J Exp Biol Med Sci       Date:  1962-08

2.  Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs.

Authors:  A A MILES; E M MILES
Journal:  J Physiol       Date:  1952-10       Impact factor: 5.182

3.  Arginine-rich proteins of polymorphonuclear leukocyte lysosomes. Antimicrobial specificity and biochemical heterogeneity.

Authors:  H I Zeya; J K Spitznagel
Journal:  J Exp Med       Date:  1968-05-01       Impact factor: 14.307

4.  Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin.

Authors:  D G Colley
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

5.  Hydrolysis of proteins with p-toluenesulfonic acid. Determination of tryptophan.

Authors:  T Y Liu; Y H Chang
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

6.  Measurement of protein concentration with interferences optics.

Authors:  J Babul; E Stellwagen
Journal:  Anal Biochem       Date:  1969-04-04       Impact factor: 3.365

7.  The effects of mercaptoethanol and of peritoneal macrophages on the antibody-forming capacity of nonadherent mouse spleen cells in vitro.

Authors:  C Chen; J G Hirsch
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

8.  Promotion of replication in lymphoid cells by specific thiols and disulfides in vitro. Effects on mouse lymphoma cells in comparison with splenic lymphocytes.

Authors:  J D Broome; M W Jeng
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

9.  Bactericidal action of histone.

Authors:  J G HIRSCH
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

10.  In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

Authors:  S Cohen; P A Ward
Journal:  J Exp Med       Date:  1971-01-01       Impact factor: 14.307

View more
  25 in total

1.  Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.

Authors:  G J Gleich; D A Loegering; K G Mann; J E Maldonado
Journal:  J Clin Invest       Date:  1976-03       Impact factor: 14.808

2.  Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy.

Authors:  C J Spry; P C Tai
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Selective inflammatory response induced by intratracheal and intravenous administration of poly-L-arginine in guinea pig lungs.

Authors:  D Arseneault; K Maghni; P Sirois
Journal:  Inflammation       Date:  1999-06       Impact factor: 4.092

Review 4.  The human eosinophil: roles in host defense and tissue injury.

Authors:  P F Weller; E J Goetzl
Journal:  Am J Pathol       Date:  1980-09       Impact factor: 4.307

5.  Distribution of major basic protein on human airway following in vitro eosinophil incubation.

Authors:  Ailing Xue; John Wang; Gary C Sieck; Mark E Wylam
Journal:  Mediators Inflamm       Date:  2010-03-22       Impact factor: 4.711

6.  Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor.

Authors:  T L Wasmoen; C B Coulam; K M Leiferman; G J Gleich
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

7.  Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease.

Authors:  A Slungaard; G M Vercellotti; T Tran; G J Gleich; N S Key
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Killing of juvenile Fasciola hepatica by purified bovine eosinophil proteins.

Authors:  W P Duffus; K Thorne; R Oliver
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

9.  Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract.

Authors:  W B Davis; G A Fells; X H Sun; J E Gadek; A Venet; R G Crystal
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

10.  Mechanisms for eosinophil degranulation; release of the eosinophil cationic protein.

Authors:  I Winqvist; T Olofsson; I Olsson
Journal:  Immunology       Date:  1984-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.